Cibc World Market Inc. Has $163.56 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Cibc World Market Inc. grew its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 65.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 323,338 shares of the healthcare conglomerate's stock after purchasing an additional 128,447 shares during the period. Cibc World Market Inc.'s holdings in UnitedHealth Group were worth $163,564,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. Kathleen S. Wright Associates Inc. acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $27,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at $30,000. Global Wealth Strategies & Associates increased its stake in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock valued at $31,000 after buying an additional 32 shares during the last quarter. West Financial Advisors LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $32,000. Finally, Quarry LP increased its stake in UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate's stock valued at $33,000 after buying an additional 37 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

UNH stock traded up $1.78 during trading on Friday, reaching $547.35. 1,197,537 shares of the company were exchanged, compared to its average volume of 4,412,382. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market capitalization of $503.72 billion, a price-to-earnings ratio of 35.32, a P/E/G ratio of 1.46 and a beta of 0.62. The company has a 50-day moving average of $537.14 and a two-hundred day moving average of $564.96.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the previous year, the firm posted $5.83 EPS. The company's revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.64 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.53%. The ex-dividend date was Monday, December 9th. UnitedHealth Group's dividend payout ratio is currently 54.19%.

Insider Activity

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business's stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.33% of the company's stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of analyst reports. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. UBS Group decreased their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating for the company in a research report on Wednesday, October 16th. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a research report on Wednesday, October 16th. KeyCorp reaffirmed an "overweight" rating and set a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, HSBC raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price for the company in a report on Friday, January 10th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.